Literature DB >> 22241181

A multi-centre pathologist survey on pathological processing and regression grading of colorectal cancer resection specimens treated by neoadjuvant chemoradiation.

Runjan Chetty1, Pelvender Gill, Dhirendra Govender, Adrian Bateman, Hee Jin Chang, David Driman, Fraser Duthie, Marisa Gomez, Eleanor Jaynes, Cheok Soon Lee, Michael Locketz, Claudia Mescoli, Corwyn Rowsell, Anne Rullier, Stefano Serra, Neil Shepherd, Eva Szentgyorgyi, Rajkumar Vajpeyi, Lai Mun Wang.   

Abstract

To ascertain the approach and degree of consensus of pathologists in the handling and regression grading of colorectal cancer resection specimens treated with neoadjuvant chemoradiation, a ten-part questionnaire was circulated to 18 gastrointestinal pathologists in eight countries. The questions were specific and addressed pertinent issues related to colorectal cancer with neoadjuvant chemoradiation. There is a lack of consensus on how to handle the specimen, number of sections taken, correlation with pre- and post-operative radiological imaging, and especially, regression grading schema employed. Consensus in the form of guidelines is required so that the pathological assessment of these specimens will provide clinically relevant information for patient management, irrespective of location.

Entities:  

Mesh:

Year:  2012        PMID: 22241181     DOI: 10.1007/s00428-012-1193-3

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  20 in total

1.  Preoperative radiotherapy for resectable rectal cancer: A meta-analysis.

Authors:  C Cammà; M Giunta; F Fiorica; L Pagliaro; A Craxì; M Cottone
Journal:  JAMA       Date:  2000 Aug 23-30       Impact factor: 56.272

2.  Prognostic implications of downstaging following preoperative radiation therapy for operable T3-T4 rectal cancer.

Authors:  M C Kaminsky-Forrett; T Conroy; E Luporsi; D Peiffert; M Lapeyre; P Boissel; F Guillemin; P Bey
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-12-01       Impact factor: 7.038

3.  Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experience.

Authors:  N A Janjan; V S Khoo; J Abbruzzese; R Pazdur; R Dubrow; K R Cleary; P K Allen; P M Lynch; G Glober; R Wolff; T A Rich; J Skibber
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-07-15       Impact factor: 7.038

4.  The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer.

Authors:  Fabio Maria Vecchio; Vincenzo Valentini; Bruce D Minsky; Gilbert D A Padula; Ennapadam S Venkatraman; Mario Balducci; Francesco Miccichè; Riccardo Ricci; Alessio Giuseppe Morganti; Maria Antonietta Gambacorta; Francesca Maurizi; Claudio Coco
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-07-01       Impact factor: 7.038

5.  Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.

Authors:  Claus Rödel; Peter Martus; Thomas Papadoupolos; Laszlo Füzesi; Martin Klimpfinger; Rainer Fietkau; Torsten Liersch; Werner Hohenberger; Rudolf Raab; Rolf Sauer; Christian Wittekind
Journal:  J Clin Oncol       Date:  2005-10-24       Impact factor: 44.544

6.  Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy.

Authors:  Hanifa Bouzourene; Fred T Bosman; Walter Seelentag; Maurice Matter; Philippe Coucke
Journal:  Cancer       Date:  2002-02-15       Impact factor: 6.860

7.  Pathology data in the central databases of multicenter randomized trials need to be based on pathology reports and controlled by trained quality managers.

Authors:  I D Nagtegaal; E K Kranenbarg; J Hermans; C J van de Velde; J H van Krieken
Journal:  J Clin Oncol       Date:  2000-04       Impact factor: 44.544

8.  Pathological features of rectal cancer after preoperative radiochemotherapy.

Authors:  O Dworak; L Keilholz; A Hoffmann
Journal:  Int J Colorectal Dis       Date:  1997       Impact factor: 2.571

9.  Rectal cancer staging post neoadjuvant therapy--how should the changes be assessed?

Authors:  Adrian C Bateman; Eleanor Jaynes; Andrew R Bateman
Journal:  Histopathology       Date:  2009-05       Impact factor: 5.087

10.  Short-term preoperative radiotherapy interferes with the determination of pathological parameters in rectal cancer.

Authors:  Iris D Nagtegaal; Corrie A M Marijnen; Elma Klein Kranenbarg; Adri Mulder-Stapel; Jo Hermans; Cornelis J H van de Velde; J Han J M van Krieken
Journal:  J Pathol       Date:  2002-05       Impact factor: 7.996

View more
  6 in total

Review 1.  Tumor regression grading of gastrointestinal cancers after neoadjuvant therapy.

Authors:  Rupert Langer; Karen Becker
Journal:  Virchows Arch       Date:  2017-09-16       Impact factor: 4.064

Review 2.  Controversies in the pathological assessment of colorectal cancer.

Authors:  Aoife Maguire; Kieran Sheahan
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

Review 3.  Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR).

Authors:  W Glenn McCluggage; Meagan J Judge; Blaise A Clarke; Ben Davidson; C Blake Gilks; Harry Hollema; Jonathan A Ledermann; Xavier Matias-Guiu; Yoshiki Mikami; Colin J R Stewart; Russell Vang; Lynn Hirschowitz
Journal:  Mod Pathol       Date:  2015-06-19       Impact factor: 7.842

Review 4.  Defining response to radiotherapy in rectal cancer using magnetic resonance imaging and histopathological scales.

Authors:  Muhammed R S Siddiqui; Jemma Bhoday; Nicholas J Battersby; Manish Chand; Nicholas P West; Al-Mutaz Abulafi; Paris P Tekkis; Gina Brown
Journal:  World J Gastroenterol       Date:  2016-10-07       Impact factor: 5.742

5.  Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer.

Authors:  Francesco Sclafani; Gina Brown; David Cunningham; Andrew Wotherspoon; Larissa Sena Teixeira Mendes; Svetlana Balyasnikova; Jessica Evans; Clare Peckitt; Ruwaida Begum; Diana Tait; Josep Tabernero; Bengt Glimelius; Susana Roselló; Janet Thomas; Jacqui Oates; Ian Chau
Journal:  Br J Cancer       Date:  2017-09-21       Impact factor: 7.640

Review 6.  Tumor regression grading of gastrointestinal carcinomas after neoadjuvant treatment.

Authors:  Svenja Thies; Rupert Langer
Journal:  Front Oncol       Date:  2013-10-07       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.